Patients with <7/8 transplants had a 1-year survival of 85.6% versus 78.6% for those who received better-matched donor cells.

Discover why CLLS is a top speculative Buy, with promising CAR-T therapies, strong big pharma partnerships, and attractive ...

Researchers at The University of Texas MD Anderson Cancer Center have characterized the complex microenvironment in ...

ORLANDO -- A gene therapy that could transform CAR T-cell treatment achieved rapid and potentially durable measurable ...

Interrupting one function of a protein that plays a key role in cell signaling could enable the development of new cancer ...

IMA203CD8 is a second-generation PRAME cell therapy with enhanced pharmacology in ongoing Phase 1a dose escalationManageable ...

We know that the process of viral uptake into cells begins with interactions between proteins hemagglutinin and neuraminidase ...

Researchers at The University of Texas MD Anderson Cancer Center have characterized the complex microenvironment in angioimmunoblastic T cell lymphoma (AITL), a type of nodal T cell lymphoma, and ...

Pralhad Joshi champions hydrogen fuel cell EVs, highlighting their potential to revolutionize India's clean energy future ...

The U.S. Food and Drug Administration announced the approval of the first hematopoietic stem cell transplant therapy to treat ...

Positive results of ERNA-101 in ovarian cancer models demonstrated promising survival benefit and immune activation, ...

Baby Leo, a one-year-old from Cape Town, has passed the critical 100-day milestone following a life-saving stem cell ...